Retinal transplantation

Chemical Immunology and Allergy

Volumn 92, Issue , 2007, Pages 300-316

  Ng, Tat Fong ^a   Klassen, Henry J ^a,b   Hori, Junko ^c   Young, Michael J ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; FAS ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; CELL SURVIVAL; DELAYED HYPERSENSITIVITY; DONOR; EYE DISEASE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NEURAL STEM CELL; NONHUMAN; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA SURGERY; RETINAL TRANSPLANTATION; STEM CELL TRANSPLANTATION; SURGICAL TECHNIQUE; T LYMPHOCYTE; TREATMENT OUTCOME; ANIMAL; ANTIGEN PRESENTATION; BRAIN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOUSE; PHYSIOLOGY; RETINA; REVIEW; STEM CELL; TRANSPLANTATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD95; BRAIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; INTERFERON TYPE II; MICE; PIGMENT EPITHELIUM OF EYE; RETINA; STEM CELLS;

EID: 33947505589     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000099280     Document Type: Article

References (43)

1. Wenkel H, Streilein JW, Young MJ: Systemic immune deviation in the brain that does not depend on the integrity of the blood-brain barrier. J Immunol 2000;164:5125-5131.
2. Jiang LQ, Jorquera M, Streilein JW: Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest Ophthalmol Vis Sci 1993;34:3347-3354.
3. Wenkel H, Chen PW, Ksander BR, Streilein JW: Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space. Invest Ophthalmol Vis Sci 1999;40:3202-3208.
4. Jiang LQ, Streilein JW: Immunity and immune privilege elicited by autoantigens expressed on syngeneic neonatal neural retina grafts. Curr Eye Res 1992;11:697-709.
5. Jiang LQ, Streilein JW: Immune responses elicited by transplantation and tissue-restricted antigens expressed on retinal tissues implanted subconjunctivally. Transplantation 1991;52:513-519.
6. Jiang LQ, Jorquera M, Streilein JW: Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts. Exp Eye Res 1994;58:719-728.
7. Wenkel H, Streilein JW: Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest Ophthalmol Vis Sci 1998;39:1823-1834.
8. Gregerson DS, Dou C: Spontaneous induction of immunoregulation by an endogenous retinal antigen. Invest Ophthalmol Vis Sci 2002;43:2984-2991.
9. Ng TF, Streilein JW: Light-induced migration of retinal microglia into the subretinal space. Invest Ophthalmol Vis Sci 2001;42:3301-3310.
10. Ng TF, Cho KS, Osawa H, Streilein JW: Bright light, by recruiting microglia to the subretinal space prejudices survival of neonatal neuronal retina allografts (abstract). Invest Ophthalmol Vis Sci 2002;43:2291.
11. Ma N, Streilein JW: T cell immunity induced by allogeneic microglia in relation to neuronal retina transplantation. J Immunol 1999;162:4482-4489.
12. Gregerson DS, Yang J: CD45-positive cells of the retina and their responsiveness to in vivo and in vitro treatment with IFN-gamma or anti-CD40. Invest Ophthalmol Vis Sci 2003;44:3083-3093.
13. Hori J, Joyce N, Streilein JW: Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule. Invest Ophthalmol Vis Sci 2000;41:443-452.
14. Reece-Smith H, Du Toit DF, McShane P, Morris PJ: Prolonged survival of pancreatic islet allografts transplanted beneath the renal capsule. Transplantation 1981;31:305-306.
15. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 1995;377:630-632.
16. Takahashi M, Palmer TD, Takahashi J, Gage FH: Widespread integration and survival of adult-derived neural progenitor cells in the developing optic retina. Mol Cell Neurosci 1998;12: 340-348.
17. Young MJ, Ray SJO, Whiteley SJO, Klassen HJ, Gage FH: Integration of transplanted neural progenitor cells into the retina of immature and mature dystrophic rats. Mol Cell Neurosci 2000;16: 197-205.
18. Farrokh-Siar L, Rezai KA, Semnani RT, Patel SC, Ernest JT, Peterson EJ, Koretzky GA, van Seventer GA: Human fetal retinal pigment epithelial cells induce apoptosis in the T-cell line Jurkat. Invest Ophthalmol Vis Sci 1999;40:1503-1511.
19. Kaestel CG, Lovato P, Odum N, Nissen MH, Ropke C: The immune privilege of the eye: Human retinal pigment epithelial cells selectively modulate T-cell activation in vitro. Curr Eye Res 2005;30:375-383.
20. Sun D, Enzmann V, Lei S, Sun SL, Kaplan HJ, Shao H: Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels. J Neuroimmunol 2003;144:1-8.
21. Willermain F, Caspers-Velu L, Nowak B, Stordeur P, Mosselmans R, Salmon I, Velu T, Bruyns C: Retinal pigment epithelial cells phagocytosis of T lymphocytes: Possible implication in the immune privilege of the eye. Br J Ophthalmol 2002;86:1417-1421.
22. Wenkel H, Streilein JW: Evidence that retinal pigment epithelium functions as an immuneprivileged tissue. Invest Ophthalmol Vis Sci 2000;41:3467-3473.
23. Ng TF, Osawa H, Hori J, Young MJ, Streilein JW: Allogeneic neonatal neuronal retina grafts display partial immune privilege in the subcapsular space of the kidney. J Immunol 2002;169: 5601-5606.
24. Ma N, Streilein JW: Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts. Invest Ophthalmol Vis Sci 1998;39:2384-2393.
25. Gage FH, Ray J, Fisher LJ: Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci 1995;18:159-192.
26. Yandava BD, Billinghurst LL, Snyder EY: 'Global' cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 1999;96:7029-7034.
27. Huh GS, Boulanger LM, Du H, Riquelme PA, Brotz TM, Shatz CJ: Functional requirement for class I MHC in CNS development and plasticity. Science 2000;290:2155-2159.
28. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
29. Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD, Huggins GR, Gearhart JD: Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 1998;95:13726-13731.
30. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL: Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999;283:534-537.
31. Clarke DL, Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlstrom H, Lendahl U, Frisen J: Generalized potential of adult neural stem cells. Science 2000;288:1660-1663.
32. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-1234.
33. Madrazo I, Leon V, Torres C, Aguilera MC, Varela G, Alvarez F, Fraga A, Drucker-Colin R, Ostrosky F, Skurovich M, Franco R: Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N Engl J Med 1988;318:51.
34. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344:710-719.
35. Hagell P, Schrag A, Piccini P, Jahanshahi M, Brown R, Rehncrona S, Widner H, Brundin P, Rothwell JC, Odin P, Wenning GK, Morrish P, Gustavii B, Bjorklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O: Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft. Brain 1999;122:1121-1132.
36. Klassen H, Imfeld KL, Ray J, Young MJ, Gage FH, Berman MA: The immunological properties of adult hippocampal progenitor cells. Vision Res 2003;43:947-956.
37. Hori J, Ng TF, Shatos M, Klassen H, Streilein JW, Young MJ: Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003;21:405-416.
38. Klassen H, Schwartz MR, Bailey AH, Young MJ: Surface markers expressed by multipotent human and mouse neural progenitor cells include tetraspanins and non-protein epitopes. Neurosci Lett 2001;312:180-182.
39. Schwartz PH, Bryant PJ, Fuja TJ, Su H, O'Dowd DK, Klassen H: Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res 2003;74:838-851.
40. Klassen H, Ziaeian B, Kirov II, Young MJ, Schwartz PH: Isolation of retinal progenitor cells from post-mortem human tissue and comparison with autologous brain progenitors. J Neurosci Res 2004;77:334-343.
41. Ahmad I, Dooley CM, Thoreson WB, Rogers JA, Afiat S: In vitro analysis of a mammalian retinal progenitor that gives rise to neurons and glia. Brain Res 1999;831:1-10.
42. Yang P, Seiler MJ, Aramant RB, Whittemore SR: Differential lineage restriction of rat retinal progenitor cells in vitro and in vivo. J Neurosci Res 2002;69:466-476.
43. Schwartz PH, Nethercott H, Kirov II, Ziaeian B, Young MJ, Klassen H: Expression of neurodevelopmental markers by cultured porcine neural precursor cells. Stem Cells 2005;23:1286-1294.